Targeting Sickle Cell Disease (Sponsored Content)

episode

Bloomberg Businessweek not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Russia’s New Drone Threat Raises Alarms in Ukraine 21 min · 27 Sep 2026 · The MeidasTouch Podcast

FULL SHOW: Evict My House Guest Awkward, Whatcha Doin’ at Oktoberfest + Prison Prank (9/22/26) 55 min · 27 Sep 2026 · Brooke and Jeffrey: Second Date Update

The Inherited Mindset: Firing Your Family’s Financial Beliefs 3 min · 27 Sep 2026 · The Level Up Podcast w/ Paul Alex

The Rise of the AI Moderates 32 min · 27 Sep 2026 · The AI Daily Brief: Artificial Intelligence News and Analysis

NPR News: 09-27-2026 7AM EDT 5 min · 27 Sep 2026 · NPR News Now

7AM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded13 Oct 2024

Publisheromnycontent.com ↗

Handlerec:3275180

Show notes

Terri Booker’s body burns with pain. She’s one of the 100,000 Americans living with sickle cell disease – a blood disorder that can cause severe pain, organ failure, and even premature death. The genetic condition came about to protect against malaria. Dr. William Hobbs leads clinical development for sickle cell disease at Vertex, and they are investigating multiple approaches to address the unmet needs that patients face. This episode of Targeting the Toughest Diseases is sponsored by Vertex Pharmaceuticals.See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in